NCT04154163View on ClinicalTrials.gov

Appropriate Dosing to Optimise Personalised Cancer Treatments

CompletedOBSERVATIONAL
Enrollment

18

Participants

Timeline

Start Date

January 10, 2020

Primary Completion Date

March 5, 2021

Study Completion Date

March 5, 2021

Conditions
Melanoma Stage IIIMelanoma Stage IVOvarian CancerRenal Cancer Stage IIIRenal Cancer Stage IVLung Cancer, Non-small Cell
Interventions
DIAGNOSTIC_TEST

Dried blood Spot (DBS)

Dried Blood Spot filter paper and sponges

DIAGNOSTIC_TEST

Venous blood sampling

Venous blood

Trial Locations (1)

DD1 9SY

NHS Tayside and University of Dundee, Dundee

All Listed Sponsors
lead

University of Dundee

OTHER

NCT04154163 - Appropriate Dosing to Optimise Personalised Cancer Treatments | Biotech Hunter | Biotech Hunter